• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Vyluma Meets With FDA On Atropine Sulfate For Pediatric Myopia

    GLOBENEWSWIRE

    Enforcement Report - Week of January 24, 2024

    FDA

    Mankind`s Generic Atropine Sulfate Receives Approval in the U.S.

    FDA

    Hospira, Inc. Issues A Voluntary Nationwide Recall For 4.2% Sodium Bicarbonate Injection, 8.4% Sodium Bicarbonate Injection, and Atropine Sulfate Injection Due to the Potential Presence of Glass Particulate Matter

    FDA

    Medefil Announces Availability of FDA-Approved Emergency Syringes

    BUSINESSWIRE

    Enforcement Report - Week of June 7, 2023

    FDA

    Enforcement Report - Week of February 15, 2023

    FDA

    Enforcement Report - Week of February 1, 2023

    FDA

    Medefil`s Generic Atropine Sulfate Receives Approval in the U.S.

    FDA

    Amneal launches 4 new Generic products, including Vasopressin single-dose

    BUSINESSWIRE

    Australia registers feye drops to slow short-sightedness progress in children

    BIOSPECTRUMASIA

    Amneal Expands Injectables Portfolio with 4 New Products

    BUSINESSWIRE

    Amneal`s Generic Atropine Sulfate Receives Approval in U.S.

    FDA

    Phytex announces Atropine Base & Atropine Sulfate for supply

    PRESS RELEASE

    Apotex Announces Approval & Launch of Atropine Sulfate Solution USP, 1%

    PRNEWSWIRE

    Hikma`s Generic Atropine Sulfate gets Approval in the U.S.

    FDA

    Apotex Inc`s Generic Atropine Sulfate Receives Approval in US

    FDA

    Enforcement Report - Week of January 13, 2021

    FDA

    Intl Medication Sys`s Generic Atropine Sulfate Receives Approval In US

    FDA

    Mayne Pharma Generic Atropine Sulfate;Diphenoxylate HCL Receives Approval In US

    FDA

    Enforcement Report - Week of March 11, 2020

    FDA

    Leading Pharma`s Generic Atropine Sulfate;Diphenoxylate Hydrochloride Receives Approval In US

    FDA

    Premier Pharmacy Labs Issues Voluntary Nationwide Recall of all Unexpired Sterile Drug Product Lots Due to Lack of Sterility Assurance

    FDA

    Alchem launches micronized digoxin platform

    BIOSPECTRUMASIA

    Bayshore Pharms` Generic Atropine Sulfate; Diphenoxylate Hydrochloride Approved in US

    FDA

    Upsher-Smith Launches Generic Version of Lomotil tablets

    PR NEWSWIRE

    Enforcement Report - Week of March 14, 2018

    FDA

    Enforcement Report - Week of February 28, 2018

    FDA

    Fresenius Kabi USA Generic Atropine Sulfate Receives Approval In US

    FDA

    Enforcement Report - Week of January 10, 2018

    FDA

    Greenstone Issues Voluntary Nationwide Recall of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP

    FDA

    RedHill Announces US Commercialization Agreement Product Esomeprazole Strontium

    GLOBENEWSWIRE

    Hospira recalls injected dextrose for infants

    FIERCE PHARMA

    NPPA revises ceiling prices of 22 scheduled drugs and RP of 13 formulations

    PHARMABIZ

    RedHill Biopharma and Concordia to co-promote GI drug, Donnatal in US market

    PHARMABIZ

    Drug shortages become issue in Teva and Mylan hook-up

    FIERCE PHARMA MANUFACTURING

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.